Aleixo Pharma
Levosulpiride (75mg) + Esomeprazole (40mg)
Impraz L Capsule SR is a prescription medicine used to treat gastroesophageal reflux disease (acid reflux) by relieving symptoms such as heartburn, stomach pain, or irritation.
Capsule SR
Impraz L Capsule SR is a prescription medicine used in the treatment of gastroesophageal reflux disease (acid reflux). It works by relieving the symptoms such as heartburn, stomach pain, or irritation. It also neutralizes the acid production in the stomach to prevent discomfort.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Impraz L Capsule SR is to be taken empty stomach.
Impraz L Capsule SR is a combination of two medicines: Levosulpiride and Esomeprazole.
It is a well-tolerated medicine and provides relief for a long time. Take it one hour before the meal, preferably in the morning. Inform your doctor if you get watery diarrhea, fever, or stomach pain that does not go away. Do not consume alcohol while taking Impraz L Capsule SR as it can increase the risk of stomach damage. Long-term use may cause weak or broken bones. Take adequate intake of dietary calcium and vitamin D or their supplements. Do not take Impraz L Capsule SR for longer than prescribed.
Store Impraz L Capsule SR in its original container, tightly closed, according to the instructions on the pack or label. Dispose of unused medication properly, ensuring it is not accessible to pets, children, or other individuals.
Take Impraz L Capsule SR exactly as directed by your doctor. For optimal results, take one capsule daily on an empty stomach.
Impraz L Capsule SR should be avoided in patients with a known allergy to any of its components or excipients.
Yes, Impraz L Capsule SR may cause dizziness (feeling faint, weak, unsteady, or lightheaded) in some patients. If you experience dizziness or lightheadedness, it is recommended to rest for a while and resume once you feel better.
Several studies in adults suggest that treatment with Impraz L Capsule SR may be associated with an increased risk of osteoporosis-related fractures of the hip, wrist, or spine. This increased risk is more pronounced in patients receiving high doses (multiple daily doses) and long-term therapy (a year or longer).